FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. Infusion Options, Inc.

    FDA found Infusion Options produced sterile compounded drugs under insanitary conditions and failed 503B labeling and reporting rules.

    High risk
  2. Adamson Analytical Laboratories, Inc.

    FDA warned California contract drug-testing lab Adamson over inadequate computer controls and data integrity failures.

    High risk
  3. DongBang Cosmetics Co., Ltd.

    DongBang Cosmetics of Incheon shipped a hand sanitizer labeled 62% alcohol that tested at 55%, and it was refused at the U.S. border.

    High risk
  4. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy its compounded drugs missed outsourcing-facility conditions, including labeling and adverse-event reporting.

    Medium
  5. New Green Nutrition, Inc.

    FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.

    High risk
  6. Joseph A. Zadra, M.D.

    FDA warned clinical investigator Dr. Zadra for enrolling an ineligible subject and skipping required safety labs in a drug study.

    High risk
  7. AriBio H&B Co., Ltd.

    FDA warns AriBio H&B over subpotent Hand Sanitizer Original labeled 70% ethanol but tested at 58%, plus misbranding.

    High risk
  8. Marcus Research Laboratory, Inc.

    FDA warned Marcus Research Laboratory after a May 2021 inspection found it released povidone iodine API made after reactor fires and smoke without fully testing for contamination.

    High risk
  9. Sircle Laboratories, LLC

    Sircle Laboratories' drugs are adulterated (not meeting legal quality standards) due to poor CGMP (manufacturing quality rule) oversight of contract manufacturers (outside makers).

    Medium
  10. Lauren R. Klein, MD, M.S.

    FDA cited Dr. Lauren R. Klein for running two emergency department drug studies without required investigational new drug applications.

    High risk
  11. Jon B. Cole, MD

    FDA warns Dr. Jon B. Cole he ran two pre-hospital drug studies without required INDs, adding risks for pregnant women, children, and intoxicated patients.

    High risk
  12. Notarika, S.A. de C.V.

    Notarika’s Greenfrog hand sanitizer was refused at the U.S. border after FDA found methanol instead of ethanol.

    High risk
  13. GuangZhou YouXing Cosmetic Co., Ltd

    FDA found Guangzhou YouXing's V&W hand sanitizer labeled 75% ethanol contained only 35%, and refused its import as adulterated and unapproved.

    High risk
  14. RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.

    FDA says RAAS Nutritionals ran human drug studies without required IND applications, despite claiming products were dietary supplements.

    High risk
  15. Missouri Analytical Laboratories Inc

    Missouri Analytical Laboratories, a contract drug testing lab, cited for manufacturing practice violations including inadequate out-of-specification investigations and data integrity failures.

    High risk
  16. HealthMEDS Inc.

    HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.

    Medium
  17. Limpo Quimicos, SA de CV

    Limpo Quimicos' hand sanitizers were refused at the U.S. border after FDA found methanol substitution and low ethanol.

    High risk
  18. Healthy Foods & Nutrition Lab de Mexico S.A. de C.V.

    Healthy Foods & Nutrition Lab de Mexico shipped hand sanitizer labeled 70% alcohol that tested at 13%, and lacked drug approval.

    High risk
  19. True Chemical Solutions, LLC

    FDA cites True Chemical Solutions over unanswered hand sanitizer records requests.

    Medium
  20. Ardil Comercial S.R.L.

    FDA found Ardil Comercial's Limar hand sanitizer contained less isopropyl alcohol and undeclared ethanol and was packaged like a water bottle.

    High risk
  21. Walfer Corporation dba The Medicine Shoppe Pharmacy

    FDA warned The Medicine Shoppe Pharmacy in Port Charlotte, Florida, over insanitary compounding conditions, vermin, and drugs made without valid prescriptions.

    High risk
  22. Strategia Project Management, Inc.

    FDA warned Strategia Project Management that its microSURE Hand Sanitizer is an unapproved, misbranded drug marketed with COVID-19 claims.

    High risk
  23. Laboratorio Pharma International SRL

    FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.

    High risk
  24. Nanomateriales Químicos Avanzados, S.A. de C.V.

    FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.

    High risk
  25. Furley Bioextracts SDN BHD

    FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.

    High risk
  26. McDaniel Water, LLC

    FDA told McDaniel Water its Black Indian Salve is an unapproved new drug because it is a corrosive topical product sold with disease-treatment claims.

    High risk
  27. Kaleido Biosciences, Inc.

    Kaleido Biosciences ran COVID-19 clinical trials of KB109 without required IND, FDA says.

    High risk
  28. Genesis Nutrition Ultra Slim dba Genesis Ultra Slim

    Genesis Nutrition Ultra Slim sells Genesis Ultra Slim Gold, a weight-loss product that contains undeclared sibutramine and phenolphthalein.

    High risk
  29. 247rxpill.in

    FDA warned website 247rxpill.in for selling unapproved opioid and benzodiazepine drugs to U.S. consumers.

    High risk
  30. PowerAll Pharma

    FDA warned PowerAll Pharma for selling unapproved, misbranded opioid and benzodiazepine drugs online without prescriptions.

    High risk
  31. AnazaoHealth Corporation

    AnazaoHealth Corporation compounded drugs without meeting 503B conditions, including inadequate adverse event reporting.

    Medium
  32. Pharmaceutical Care Solutions dba Pharmacy Solutions

    FDA warns Pharmaceutical Care Solutions dba Pharmacy Solutions over compounded drugs made with ineligible bulk substances and lacking FDA approval.

    Medium
  33. Gulsah Uretim Kozmetik Sanayi Anonim Sirketi

    Turkish OTC drug maker Gulsah failed to test its products and ingredients, and FDA blocked its U.S. imports.

    High risk
  34. Toyobo Co. Ltd.

    FDA warned Toyobo after inspection found unresolved particulate contamination and environmental monitoring data manipulation affecting sterile injectable drugs.

    High risk
  35. Je Dois Lavoir LLC

    Je Dois Lavoir sells 365 Skinny High Intensity weight-loss drug containing undeclared sibutramine without FDA approval.

    High risk
  36. Natural Beauty Care Pty Ltd

    FDA warned Natural Beauty Care Pty Ltd that its OTC drugs are adulterated due to CGMP failures and no finished-product or ingredient testing.

    High risk
  37. Mahita, LLC dba PushMyCart

    FDA and FTC warn Mahita/PushMyCart over unapproved Ayurvedic/homeopathic COVID-19 treatment claims.

    High risk
  38. Tropicosmeticos SA de CV

    FDA found Tropicosmeticos SA de CV’s Britz hand sanitizer labeled 70% ethanol contained 0% ethanol and >50% methanol.

    High risk
  39. Maitland Labs of Central Florida

    FDA warns Maitland Labs of Central Florida over sterile compounded drugs with manufacturing quality failures, mislabeling, and unapproved new drug violations.

    High risk
  40. Secret of the Islands

    FDA warned Secret of the Islands that its salt scrub products are unapproved and misbranded drugs because of COVID-19 claims.

    High risk
  41. BBC Group Limited

    FDA cites BBC Group Limited for data integrity, lab, equipment failures and unapproved, misbranded hand sanitizers.

    High risk
  42. Sanit Technologies, LLC dba Durisan

    FDA says Sanit Technologies (Durisan) released contaminated alcohol-free hand sanitizer, including Burkholderia cepacia, made with contaminated water.

    High risk
  43. Blue Willow Biologics

    FDA warned Blue Willow Biologics over its NanoBio Protect nasal antiseptic sold with unapproved COVID-19 prevention and treatment claims.

    High risk
  44. Farmakeio Outsourcing LLC

    FDA warns Farmakeio Outsourcing over inadequate adverse event reporting and unapproved, misbranded compounded testosterone pellets.

    Medium
  45. Syntec Pharma Corp

    FDA warned Syntec Pharma Corp, an API repackager in Farmingdale, New York, that weak cross-contamination controls and quality oversight made its drugs adulterated.

    High risk
  46. MB Solutions, LLC/BioSpectrum CBD

    FDA warned BioSpectrum CBD over unapproved CBD nasal sprays, roll-on, edibles, and dog products sold online.

    High risk
  47. rxmedkart.com

    FDA warned rxmedkart.com it sells unapproved, misbranded drugs online, including a COVID-19 'Ziverdo Kit.'

    High risk
  48. MasterPharm LLC

    FDA warned MasterPharm over compounded Finasteride Plus capsules with excess finasteride, undeclared minoxidil, and insanitary aseptic conditions.

    High risk
  49. Sck Zeta Dis Ticaret, Pazarlama Ltd.

    FDA says Turkish maker Sck Zeta's NEUTREVO hand sanitizer contained methanol instead of labeled ethanol and was refused at US border.

    High risk
  50. Jordan’s Crossing Herbal Connections

    FDA warned Jordan’s Crossing Herbal Connections that its Germaphobe’s Delight Spray was an unapproved, misbranded drug with COVID-19 claims.

    High risk